Sana Biotechnology Stock Price on January 5, 2024
| SANA Stock | USD 2.78 0.23 9.02% |
If you're considering investing in Sana Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sana Biotechnology stands at 2.78, as last reported on the 1st of December, with the highest price reaching 2.83 and the lowest price hitting 2.55 during the day. Sana Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.21, which indicates the firm had a -0.21% return per unit of risk over the last 3 months. Sana Biotechnology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sana Biotechnology's Coefficient Of Variation of (471.53), risk adjusted performance of (0.15), and Variance of 22.68 to confirm the risk estimate we provide.
At present, Sana Biotechnology's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 677.9 M, whereas Total Stockholder Equity is forecasted to decline to about 172 M. . At present, Sana Biotechnology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.90, whereas Price Earnings Ratio is forecasted to decline to (2.94). Sana Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sana |
Sharpe Ratio = -0.2075
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SANA |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.98 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sana Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sana Biotechnology by adding Sana Biotechnology to a well-diversified portfolio.
Price Book 2.1222 | Book Value 1.311 | Enterprise Value 517.8 M | Enterprise Value Ebitda (1.08) | Shares Float 130.9 M |
Related Headline
Day One Headline on 5th of January 2024
Acquisition by York Charles N Ii of 106000 shares of Day One... by York Charles N Ii
Filed transaction by Day One Biopharmaceutical officer. Grant, award or other acquisition pursuant to Rule 16b-3
Sana Biotechnology Valuation on January 5, 2024
It is possible to determine the worth of Sana Biotechnology on a given historical date. On January 5, 2024 Sana was worth 5.0 at the beginning of the trading date compared to the closed value of 5.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sana Biotechnology stock. Still, in general, we apply an absolute valuation method to find Sana Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sana Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sana Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 4.73 | 4.97 | 4.46 | 4.90 | 3,893,495 | |
01/05/2024 | 5.00 | 5.54 | 4.64 | 5.10 | 5,036,840 |
| 4.90 | 5.29 | 4.86 | 5.08 | 3,105,178 |
| Backtest Sana Biotechnology | | | Sana Biotechnology History | | | Sana Biotechnology Valuation | Previous | Next |
Sana Biotechnology Trading Date Momentum on January 5, 2024
| On January 08 2024 Sana Biotechnology was traded for 5.08 at the closing time. The top price for the day was 5.29 and the lowest listed price was 4.86 . The trading volume for the day was 3.1 M. The trading history from January 8, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.39% . The trading price change against the current closing price is 27.65% . |
Sana Biotechnology Fundamentals Correlations and Trends
By evaluating Sana Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sana Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sana financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sana Biotechnology Stock history
Sana Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sana is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sana Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sana Biotechnology stock prices may prove useful in developing a viable investing in Sana Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 194.5 M | 203.8 M | |
| Net Loss | -242.5 M | -254.7 M |
Sana Biotechnology Quarterly Net Working Capital |
|
Sana Biotechnology Stock Technical Analysis
Sana Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sana Biotechnology Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Sana Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sana Biotechnology December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Sana Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sana Biotechnology shares will generate the highest return on investment. By undertsting and applying Sana Biotechnology stock market strength indicators, traders can identify Sana Biotechnology entry and exit signals to maximize returns
Sana Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sana Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Sana Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sana to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (1.81) | |||
| Treynor Ratio | (0.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |